Molecularly engineering a dual-drug nanoassembly for self-sensitized photodynamic therapy via thioredoxin impairment and glutathione depletion

MLA

Hongyuan Zhang, et al. “Molecularly Engineering a Dual-Drug Nanoassembly for Self-Sensitized Photodynamic Therapy via Thioredoxin Impairment and Glutathione Depletion.” Drug Delivery, vol. 29, no. 1, Dec. 2022, pp. 3281–90. EBSCOhost, https://doi.org/10.1080/10717544.2022.2141920.

APA

Hongyuan Zhang, Zhiqiang Kong, Ziyue Wang, Yao Chen, Shenwu Zhang, & Cong Luo. (2022). Molecularly engineering a dual-drug nanoassembly for self-sensitized photodynamic therapy via thioredoxin impairment and glutathione depletion. Drug Delivery, 29(1), 3281–3290. https://doi.org/10.1080/10717544.2022.2141920

Chicago

Hongyuan Zhang, Zhiqiang Kong, Ziyue Wang, Yao Chen, Shenwu Zhang, and Cong Luo. 2022. “Molecularly Engineering a Dual-Drug Nanoassembly for Self-Sensitized Photodynamic Therapy via Thioredoxin Impairment and Glutathione Depletion.” Drug Delivery 29 (1): 3281–90. doi:10.1080/10717544.2022.2141920.